Search Articles — Sudonull

Search Results

From other projects

CRISPR in vivo reduces cholesterol by 60% in VERVE-102 study

https://ymaho.com/crispr-in-vivo-reduces-cholesterol-by-60-in-verve-102-study

Single infusion of VERVE-201 sustainably lowers LDL by more than 60%. Learn how CRISPR editing is changing the hypercholesterolemia therapy market. Read the analysis.

Cholesterol gene therapy VERVE-102: NEJM data, LDL reduction by 62%

https://ymaho.com/cholesterol-gene-therapy-verve-102-nejm-data-ldl-reduction-by-62

NEJM published phase 1b results of gene therapy VERVE-102: LDL reduction by 62% after a single injection. Analysis of efficacy, risks, and prospects for patients with hypercholesterolemia. Read more.

CRISPR therapy VERVE-102 reduces cholesterol by 62% after injection

https://ymaho.com/crispr-therapy-verve-102-reduces-cholesterol-by-62-after-injection

Journal NEJM published data on the drug VERVE-102: a single CRISPR injection (base editing) reduces LDL by 62% for 18 months without serious side effects. Learn details about the revolutionary therapy.

Trump pressures Iran: nuclear deal on the verge of collapse

https://ymaho.com/trump-pressures-iran-nuclear-deal-on-the-verge-of-collapse

The US demands Iran export 400 kg of uranium within weeks. Tehran does not trust Washington. Learn three scenarios for the crisis and what will happen to oil.

PSV Eindhoven Eye Third Straight Eredivisie Title

https://lrivo.com/psv-eindhoven-eye-third-straight-eredivisie-title

PSV Eindhoven is on the verge of securing their third consecutive Eredivisie title. Discover the crucial lineup for their potential championship-winning match against FC Utrecht.

Coventry City Nears Premier League Promotion

https://lrivo.com/coventry-city-nears-premier-league-promotion

Coventry City is on the verge of returning to the Premier League after a crucial win over Derby County. Discover their path to promotion and what it means for the club.

CRISPR therapy in vivo: Intellia study 87% efficacy in HAE

https://ymaho.com/crispr-therapy-in-vivo-intellia-study-87-efficacy-in-hae

Phase 3 HAELO: single CRISPR infusion reduced hereditary angioedema attacks by 87% vs placebo. First in vivo therapy on the verge of registration. Details, insights, forecasts.

Trending Now